Systemic amyloidosis and the gastrointestinal tract

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 10, 2009, Pages 608-617

  Sattianayagam, Prayman T ^a   Hawkins, Philip N ^a   Gillmore, Julian D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ATLIZUMAB; BETA 2 MICROGLOBULIN; CODEINE PHOSPHATE; DIMETHYL SULFOXIDE; ERYTHROMYCIN; IMMUNOGLOBULIN LIGHT CHAIN; LOPERAMIDE; METOCLOPRAMIDE; OCTREOTIDE; ONDANSETRON; SERUM AMYLOID A; STEROID;

ABDOMINAL PAIN; AMYLOIDOSIS; BETA 2 MICROGLOBULIN AMYLOIDOSIS; BLOOD PROTEIN DISORDER; CROHN DISEASE; DEFECATION DISORDER; DIARRHEA; DYSPEPSIA; DYSPHAGIA; FAMILIAL AMYLOIDOSIS; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HEMATEMESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; INFLAMMATION; INTESTINAL BLEEDING; INTESTINAL DYSMOTILITY; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; MACROGLOSSIA; MALABSORPTION; NAUSEA; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; RADIODIAGNOSIS; REVIEW; SATIETY; SENILE AMYLOIDOSIS; SYSTEMIC AA AMYLOIDOSIS; SYSTEMIC AL AMYLOIDOSIS; VOMITING;

AMYLOID; AMYLOIDOSIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNOTHERAPY;

EID: 70349976070     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.147     Document Type: Review

References (80)

1. Pepys, M. B. Amyloidosis. Annu. Rev. Med. 57, 223-241 (2006).
2. Pepys, M. B. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 203-210 (2001).
3. Kyle, R. A. & Gertz, M. A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin. Hematol. 32, 45-59 (1995).
4. Dubrey, S. W. et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91, 141-157 (1998).
5. Park, M. A. et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 82, 291-298 (2003).
6. Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B. & Hawkins, P. N. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358, 24-29 (2001).
7. Gertz, M. A. & Kyle, R. A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70, 246-256 (1991).
8. 123I serum amyloid P component scintigraphy in 484 patients. Gut 42, 727-734 (1998).
9. Lachmann, H. J. et al. Natural history and outcome in systemic AA amyloidosis. N. Engl. J. Med. 356, 2361-2371 (2007).
10. Suhr, O., Danielsson, A., Holmgren, G. & Steen, L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J. Intern. Med. 235, 479-485 (1994).
11. Westermark, P., Sletten, K., Johansson, B. & Cornwell, G. G. 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA 87, 2843-2845 (1990).
12. Matsutani, H. et al. Vascular amyloid of unknown origin and senile transthyretin amyloid in the lung and gastrointestinal tract of old age: histological and immunohistochemical studies. Pathol. Int. 51, 326-332 (2001).
13. Prokaeva, T. et al. Soft tissue, joint and bone manifestations of AL amyloidosis: clinical presentation, molecular features and survival. Arthritis Rheum. 56, 3858-3868 (2007).
14. Gogel, H. K., Searles, R. P., Volpicelli, N. A. & Cornwell, G. G. 3rd. Primary amyloidosis presenting as Sjögren's syndrome. Arch. Intern. Med. 143, 2325-2326 (1983).
15. 2-microglobulin amyloidosis presenting as esophageal perforation in a hemodialysis patient. Am. J. Nephrol. 17, 524-527 (1997).
16. Rubinow, A., Burakoff, R. & Cohen, A. S. & Harris, L. D. Esophageal manometry in systemic amyloidosis: a study of 30 patients. Am. J. Med. 75, 951-956 (1983).
17. Bjerle, P., Ek, B., Linderholm, H. & Steen, L. Oesophageal dysfunction in familial amyloidosis with polyneuropathy. Clin. Physiol. 13, 57-69 (1993).
18. Battle, W. M., Rubin, M. R., Cohen, S. & Snape, W. J. Jr. Gastrointestinal-motility dysfunction in amyloidosis. N. Engl. J. Med. 301, 24-25 (1979).
19. Melkebeke, P., vandepitte, J., Hannon, R. & Fevery, J. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver. Digestion 20, 351-357 (1980).
20. Menke, D. M. et al. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin. Proc. 68, 763-767 (1993).
21. Youssef, N. et al. Fatal Dieulafoy's type ulcer in a case of AL amyloidosis [French]. Ann. Pathol. 24, 256-258 (2004).
22. Muraki, M. et al. Laceration of gastric mucosa associated with dialysis-related amyloidosis. Clin. Nephrol. 64, 448-451 (2005).
23. Hizawa, K. et al. Endoscopic hydrostatic balloon dilatation of ulcer-induced pyloric stenosis in rheumatoid arthritis and secondary amyloidosis. Surg. Endosc. 11, 673-675 (1997).
24. Suhr, O. B., Anan, I., Ahlström, K. R. & Rydh, A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy: Portugese type (val30Met). Amyloid 10, 121-126 (2003).
25. Saglam, F. et al. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Transplant. Proc. 40, 308-309 (2008).
26. Gilat, T. & Spiro, H. M. Amyloidosis and the gut. Am. J. Dig. Dis. 13, 619-633 (1968).
27. Yoshimatsu, S. et al. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30). J. Intern. Med. 243, 65-72 (1998).
28. El-Salhy, M., Suhr, O., Stenling, R., Wilander, E. & Grimelius, L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 35, 1413-1418 (1994).
29. Matsumoto, T. et al. Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis. Dig. Dis. Sci. 36, 1756-1760 (1991).
30. Feurle, G. E. Pathophysiology of diarrhea in patients with familial amyloid neuropathy. Digestion 36, 13-17 (1987).
31. Suhr, O., Danielsson, A. & Steen, L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand. J. Gastroenterol. 27, 201-207 (1992).
32. Guirl, M. J. et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am. J. Gastroenterol. 98, 2219-2225 (2003).
33. Hayman, S. R., Lacy, M. Q., Kyle, R. A. & Gertz, M. A. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am. J. Med. 111, 535-540 (2001).
34. Steen, L. & Ek, B. Familial amyloidosis with polyneuropathy: a long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med. Scand. 214, 387-397 (1983).
35. Kawaguchi, M., Koizumi, F., Shimao, M. & Hirose, S. Protein-losing enteropathy due to secondary amyloidosis of the gastrointestinal tract. Acta Pathol. Jpn 43, 333-339 (1993).
36. Chang, H. S. et al. Massive small bowel bleeding in a patient with amyloidosis. Gastrointest. Endosc. 59, 126-129 (2004).
37. Mallory, A., Struthers, J. E. Jr & Kern, F. Jr. Persistent hypotension and intestinal infarction in a patient with primary amyloidosis. Gastroenterology 68, 1587-1592 (1975).
38. Rapoport, M., Yona, R., Kaufman, S., Segal, M. & Kornberg, A. Unusual bleeding manifestations of amyloidosis in patients with multiple myeloma. Clin. Lab. Haematol. 16, 349-353 (1994).
39. Yood, R. A., Skinner, M., Rubinow, A., Talarico, L. & Cohen, A. S. Bleeding manifestations in 100 patients with amyloidosis. JAMA 249, 1322-1324 (1983).
40. Caccialanza, R. et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis. Am. J. Clin. Nutr. 83, 350-354 (2006).
41. Ito, T. et al. Mechanism of constipation in familial amyloid polyneuropathy: a case report. Intern. Med. 45, 1173-1175 (2006).
42. El-Salhy, M. & Suhr, O. Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand. J. Gastroenterol. 31, 68-73 (1996).
43. Tada, S., Iida, M., Yao, T., Kitamoto, T., Yao, T. & Fujishima, M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut 34, 1412-1417 (1993).
44. Greenstein, A. J. et al. Amyloidosis and inflammatory bowel disease: a 50 year experience with 25 patients. Medicine (Baltimore) 71, 261-270 (1992).
45. Wester, A. L., vatn, M. H. & Fausa, O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962-1998. Inflamm. Bowel Dis. 7, 295-300 (2001).
46. Puchtler, H., Sweat, F. & Levine, M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10, 355-364 (1962).
47. Lachmann, H. J. et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N. Engl. J. Med. 346, 1786-1791 (2002).
48. Hawkins, P. N. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin. Sci. (Lond.) 87, 289-295 (1994).
49. Tada, S. et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest. Endosc. 36, 10-14 (1990).
50. Ebert, E. C. & Nagar, M. Gastrointestinal manifestations of amyloidosis. Am. J. Gastroenterol. 103, 776-787 (2008).
51. Yamada, M., Hatakeyama, S. & Tsukagoshi, H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum. Pathol. 16, 1206-1211 (1985).
52. Tada, S. et al. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest. Endosc. 40, 45-50 (1994).
53. Michael, H. et al. Congo-red negative colonic amyloid with scalloping of the valvulae conniventes. Gastrointest. Endosc. 53, 653-655 (2001).
54. Pollack, M. J. & Isenberg, G. A. Isolated small bowel amyloidosis seen with capsule endoscopy. Gastrointest. Endosc. 66, 829-830 (2007).
55. Dray, X. et al. Hemorrhagic bullous colitis as a primary manifestation of AL amyloidosis. Endoscopy 38, E15-E16 (2006).
56. Schmidt, H., Frühmorgen, P., Riemann, J. F. & Becker, v. Mucosal suggillation in the colon in secondary amyloidosis. Endoscopy 13, 181-183 (1981).
57. Hui, Y. T., Lam, T. W., Yee Lam, P. W., Yan Wu, W. H. & Lam, W. M. Narrow-band imaging system with magnifying endoscopy for rectal amyloidosis. Gastrointest. Endosc. 68, 400-401 (2008).
58. Tada, S. et al. Gastrointestinal amyloidosis: radiologic features by chemical types. Radiology 190, 37-42 (1994).
59. Kala, Z., valek, v. & Kysela, P. Amyloidosis of the small intestine. Eur. J. Radiol. 63, 105-109 (2007).
60. Goulding, C., O'Hanlon, D. M., Clarke, E., Kennedy, M. & Lennon, J. Primary amyloidosis of the stomach: EUS appearances. Gastrointest. Endosc. 56, 305-306 (2002).
61. Trinh, T. D., Jones, B. & Fishman, E. K. Amyloidosis of the colon presenting as ischemic colitis: a case report and review of the literature. Gastrointest. Radiol. 16, 133-136 (1991).
62. Araoz, P. A., Batts, K. P. & MacCarty, R. L. Amyloidosis of the alimentary canal: radiologic-pathologic correlation of CT findings. Abdom. Imaging 25, 38-44 (2000).
63. Gandolfi, L. et al. Endoscopic ultrasonography in the diagnosis of gastrointestinal amyloid deposits: clinical case report. Endoscopy 27, 132-134 (1995).
64. Wechalekar, A. D., Hawkins, P. N. & Gillmore, J. D. Perspectives in treatment of AL amyloidosis. Br. J. Haematol. 140, 365-377 (2008).
65. Holmgren, G. et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341, 1113-1116 (1993).
66. Tan, S. Y. et al. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int. 50, 282-289 (1996).
67. Amemori, S. et al. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J. Gastroenterol. 41, 444-449 (2006).
68. Fushimi, T. et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 12, 48-53 (2005).
69. Okuda, Y. & Takasugi, K. Successful use of humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum. 54, 2997-3000 (2006).
70. Maeshima, E., Yamada, Y. & Yukawa, S. Massive gastrointestinal hemorrhage in a case of amyloidosis secondary to rheumatoid arthritis. Scand. J. Rheumatol. 28, 262-264 (1999).
71. Costigan, D. J. & Clouse, R. E. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig. Dis. Sci. 28, 763-765 (1983).
72. Reddy, A. B., Wright, R. A., Wheeler, G. E. & Nazer, H. Nonobstructive gastroparesis in amyloidosis with metoclopramide. Arch. Intern. Med. 143, 247-248 (1983).
73. Mardinger, O., Rotenberg, l., Chaushu, G. & Taicher, S. Surgical management of macroglossia due to primary amyloidosis. Int. J. Oral Maxillofac. Surg. 28, 129-131 (1999).
74. Johnson, D. H., Guthrie, T. H., Tedesco, F. J., Griffin, J. W. & Anthony, H. F. Jr. Amyloidosis masquerading as inflammatory bowel disease with a mass lesion stimulating a malignancy. Am. J. Gastroenterol. 77, 141-145 (1982).
75. Herlenius, G., Wilczek, H. E., Larsson, M. & Ericzon, B. G. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 77, 64-71 (2004).
76. Suhr, O. et al. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig. Dis. Sci. 41, 1909-1114 (1996).
77. Läng, K., Wikström, L., Danielsson, A., Tashima, K. & Suhr, O. B. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand. J. Gastroenterol. 35, 985-989 (2000).
78. Pepys, M. B. et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254-259 (2002).
79. Pepys, M. B. in Amyloid and Amyloidosis (eds Grateau, G. et al.) 488-490 (CRC, Boca Raton, 2005).
80. Pepys, M. B. Science and serendipity. Clin. Med. 7, 562-578 (2007).